KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Operating Margin (2016 - 2025)

Elevance Health (ELV) has disclosed Operating Margin for 17 consecutive years, with 6.03% as the latest value for Q2 2025.

  • On a quarterly basis, Operating Margin changed N/A to 6.03% in Q2 2025 year-over-year; TTM through Jun 2025 was 23.37%, a N/A change, with the full-year FY2024 number at 1.16%, up 9.0% from a year prior.
  • Operating Margin was 6.03% for Q2 2025 at Elevance Health, down from 1.21% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 77.43% in Q4 2023 to a low of 103.3% in Q4 2021.
  • A 5-year average of 25.23% and a median of 6.97% in 2023 define the central range for Operating Margin.
  • Biggest YoY gain for Operating Margin was 15482bps in 2023; the steepest drop was -10021bps in 2023.
  • Elevance Health's Operating Margin stood at 103.3% in 2021, then grew by 25bps to 77.39% in 2022, then surged by 200bps to 77.43% in 2023, then crashed by -190bps to 70.0% in 2024, then skyrocketed by 91bps to 6.03% in 2025.
  • Per Business Quant, the three most recent readings for ELV's Operating Margin are 6.03% (Q2 2025), 1.21% (Q1 2025), and 70.0% (Q3 2024).